Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Jerry Olson who wrote (84303)	2/24/2000 8:55:00 AM
From: Sosmartinov	Read Replies (1) \| Respond to of 120523

ARIA <<<damn!>>> guess what, I sold my position 2 days ago wi little profit....dohhhh!...back in small (no $$) at 3 pts. higher, oh well...

To: Jerry Olson who wrote (84303)	2/24/2000 9:04:00 AM
From: HeatherN	Read Replies (1) \| Respond to of 120523

OJ, A very brief glance at ARIA provided some interesting info, for me at least. I tend to avoid biotech becuase many companies are at the mercy of the FDA and have their futures pinned on one or two drugs....great if it works, but there are so many companies. ARIA has a proprietary system for allowing greater gene expression....leading to greater protein production. This sounds boring until one realizes that proteins are being used to treat many chronic and acute diseases for which we currently do not have a cure. It was unclear to me if ARIA is doing this in vivo or only as a means for large scale (lower cost..higher profit) production. In any case, their technology could be licensed/used by others wishing to have greater gene expression in their own applications. I am always attracted to the companies with the technology and not just the drug. All this being said, I'd wait for a pullback from the open. It's been CNBCized already... Heather